Skip to contentApplication 214533
- Type
- ANDA
- Sponsor
- CAPLIN
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | INJECTABLE;INJECTION | 5MG/ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 25021-317 | labetalol hydrochloride | labetalol hydrochloride | Sagent Pharmaceuticals | ANDA | Current |
| 25021-317 | labetalol hydrochloride | labetalol hydrochloride | Sagent Pharmaceuticals | ANDA | Current |
| 65145-124 | Labetalol Hydrochloride | Labetalol Hydrochloride | Caplin Steriles Limited | ANDA | Current |
| 65145-125 | Labetalol Hydrochloride | Labetalol Hydrochloride | Caplin Steriles Limited | ANDA | Current |